Dominant psychiatric manifestations in Wilson's disease: A diagnostic and therapeutic challenge
Abstract Introduction Recognition of psychiatric manifestations of Wilson's disease (WD) has diagnostic and therapeutic implications. Objective To describe the clinical features and psychopathology of patients with WD who had initial or predominant psychiatric manifestations. Patient and method...
Gespeichert in:
Veröffentlicht in: | Journal of the neurological sciences 2008-03, Vol.266 (1), p.104-108 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 108 |
---|---|
container_issue | 1 |
container_start_page | 104 |
container_title | Journal of the neurological sciences |
container_volume | 266 |
creator | Srinivas, K Sinha, S Taly, A.B Prashanth, L.K Arunodaya, G.R Janardhana Reddy, Y.C Khanna, S |
description | Abstract Introduction Recognition of psychiatric manifestations of Wilson's disease (WD) has diagnostic and therapeutic implications. Objective To describe the clinical features and psychopathology of patients with WD who had initial or predominant psychiatric manifestations. Patient and methods Records of 15 patients with WD (M:F: 11:4), from a large cohort of 350 patients, with predominant psychiatric manifestations at onset were reviewed. Their initial diagnosis, demographic profile, family history, pre-morbid personality, clinical manifestations, treatment and outcome were recorded. Results Their mean age at diagnosis was 19.8 ± 5.8 years. Six patients were born to consanguineous parentage and two patients each had family history of WD and past history of psychiatric illness. Diagnosis of WD was suspected by detection of KF rings (all), observing sensitivity to neuroleptics ( n = 2), history of jaundice ( n = 2) and family history suggestive of WD ( n = 9). Psychiatric manifestations could be classified as affective disorder spectrum ( n = 11) and schizophreniform-illness ( n = 3). While the psychiatric symptoms improved in five patients with de-coppering therapy, seven patients needed symptomatic treatment as well. Three of the four patients who responded to de-coppering therapy were sensitive to neuroleptics. Long-term follow up of 10 patients revealed variable recovery. Conclusions Young patient with psychiatric manifestations with clues like history of jaundice, family history of neuropsychiatric manifestations and sensitivity to neuroleptics should be evaluated for WD to avoid delay in diagnosis and associated morbidity. Significant outcomes The study reemphasizes the importance of behavioral manifestations in Wilson disease in terms of diagnosis and management difficulties. Limitations Retrospective nature of the study. |
doi_str_mv | 10.1016/j.jns.2007.09.009 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70278682</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022510X07006363</els_id><sourcerecordid>70278682</sourcerecordid><originalsourceid>FETCH-LOGICAL-c502t-4b10590e5510b17e6c3df69add6b6eea56dd7e72a6f79e7a36709c98eef1e1ab3</originalsourceid><addsrcrecordid>eNp9kU2L1TAUhoMozp3RH-BGulFXrSftNB8KwjDjFwy4UNFdSJPTuam96TWnFe6_N-VeFFy4SgLPe_LyHMaecKg4cPFyqIZIVQ0gK9AVgL7HNlxJVbZKNffZBqCuy5bD9zN2TjQAgFBKP2RnXGq45AI2zNxMuxBtnIs9Hdw22DkFV-xsDD3SbOcwRSpCLL6Fkab4ggofCC3hq-IqX-1dnGjOARt9MW8x2T0u69tt7ThivMNH7EFvR8LHp_OCfX339sv1h_L20_uP11e3pWuhnsvLjkOrAdvctuMShWt8L7T1XnQC0bbCe4mytqKXGqVthATttELsOXLbNRfs-XHuPk0_l1zd7AI5HEcbcVrISKilEqrOID-CLk1ECXuzT2Fn08FwMKtVM5hs1axWDWiTrebM09Pwpduh_5s4aczAsxNgydmxTza6QH-4PEtxyUXmXh85zCp-BUyGXMDo0IeEbjZ-Cv-t8eaftBtDDPnDH3hAGqYlxezYcEO1AfN5Xf-6fZB58Y1omt81RKuR</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70278682</pqid></control><display><type>article</type><title>Dominant psychiatric manifestations in Wilson's disease: A diagnostic and therapeutic challenge</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Srinivas, K ; Sinha, S ; Taly, A.B ; Prashanth, L.K ; Arunodaya, G.R ; Janardhana Reddy, Y.C ; Khanna, S</creator><creatorcontrib>Srinivas, K ; Sinha, S ; Taly, A.B ; Prashanth, L.K ; Arunodaya, G.R ; Janardhana Reddy, Y.C ; Khanna, S</creatorcontrib><description>Abstract Introduction Recognition of psychiatric manifestations of Wilson's disease (WD) has diagnostic and therapeutic implications. Objective To describe the clinical features and psychopathology of patients with WD who had initial or predominant psychiatric manifestations. Patient and methods Records of 15 patients with WD (M:F: 11:4), from a large cohort of 350 patients, with predominant psychiatric manifestations at onset were reviewed. Their initial diagnosis, demographic profile, family history, pre-morbid personality, clinical manifestations, treatment and outcome were recorded. Results Their mean age at diagnosis was 19.8 ± 5.8 years. Six patients were born to consanguineous parentage and two patients each had family history of WD and past history of psychiatric illness. Diagnosis of WD was suspected by detection of KF rings (all), observing sensitivity to neuroleptics ( n = 2), history of jaundice ( n = 2) and family history suggestive of WD ( n = 9). Psychiatric manifestations could be classified as affective disorder spectrum ( n = 11) and schizophreniform-illness ( n = 3). While the psychiatric symptoms improved in five patients with de-coppering therapy, seven patients needed symptomatic treatment as well. Three of the four patients who responded to de-coppering therapy were sensitive to neuroleptics. Long-term follow up of 10 patients revealed variable recovery. Conclusions Young patient with psychiatric manifestations with clues like history of jaundice, family history of neuropsychiatric manifestations and sensitivity to neuroleptics should be evaluated for WD to avoid delay in diagnosis and associated morbidity. Significant outcomes The study reemphasizes the importance of behavioral manifestations in Wilson disease in terms of diagnosis and management difficulties. Limitations Retrospective nature of the study.</description><identifier>ISSN: 0022-510X</identifier><identifier>EISSN: 1878-5883</identifier><identifier>DOI: 10.1016/j.jns.2007.09.009</identifier><identifier>PMID: 17904160</identifier><identifier>CODEN: JNSCAG</identifier><language>eng</language><publisher>Shannon: Elsevier B.V</publisher><subject>Adolescent ; Adult ; Behavioral changes ; Biological and medical sciences ; Chelating Agents - therapeutic use ; Cohort Studies ; Copper - antagonists & inhibitors ; Copper - blood ; Copper - urine ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Depressive Disorder - etiology ; Depressive Disorder - psychology ; Female ; Follow-Up Studies ; Hepatolenticular Degeneration - diagnosis ; Hepatolenticular Degeneration - psychology ; Hepatolenticular Degeneration - therapy ; Humans ; Longitudinal Studies ; Male ; Medical sciences ; Mental Disorders - etiology ; Mental Disorders - psychology ; Mood Disorders - etiology ; Mood Disorders - psychology ; Neurology ; Penicillamine - therapeutic use ; Psychiatric symptoms ; Psychosis ; Psychotic Disorders - etiology ; Psychotic Disorders - psychology ; Schizophrenia - etiology ; Wilson's disease ; Zinc Sulfate - therapeutic use</subject><ispartof>Journal of the neurological sciences, 2008-03, Vol.266 (1), p.104-108</ispartof><rights>Elsevier B.V.</rights><rights>2007 Elsevier B.V.</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c502t-4b10590e5510b17e6c3df69add6b6eea56dd7e72a6f79e7a36709c98eef1e1ab3</citedby><cites>FETCH-LOGICAL-c502t-4b10590e5510b17e6c3df69add6b6eea56dd7e72a6f79e7a36709c98eef1e1ab3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0022510X07006363$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20081716$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17904160$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Srinivas, K</creatorcontrib><creatorcontrib>Sinha, S</creatorcontrib><creatorcontrib>Taly, A.B</creatorcontrib><creatorcontrib>Prashanth, L.K</creatorcontrib><creatorcontrib>Arunodaya, G.R</creatorcontrib><creatorcontrib>Janardhana Reddy, Y.C</creatorcontrib><creatorcontrib>Khanna, S</creatorcontrib><title>Dominant psychiatric manifestations in Wilson's disease: A diagnostic and therapeutic challenge</title><title>Journal of the neurological sciences</title><addtitle>J Neurol Sci</addtitle><description>Abstract Introduction Recognition of psychiatric manifestations of Wilson's disease (WD) has diagnostic and therapeutic implications. Objective To describe the clinical features and psychopathology of patients with WD who had initial or predominant psychiatric manifestations. Patient and methods Records of 15 patients with WD (M:F: 11:4), from a large cohort of 350 patients, with predominant psychiatric manifestations at onset were reviewed. Their initial diagnosis, demographic profile, family history, pre-morbid personality, clinical manifestations, treatment and outcome were recorded. Results Their mean age at diagnosis was 19.8 ± 5.8 years. Six patients were born to consanguineous parentage and two patients each had family history of WD and past history of psychiatric illness. Diagnosis of WD was suspected by detection of KF rings (all), observing sensitivity to neuroleptics ( n = 2), history of jaundice ( n = 2) and family history suggestive of WD ( n = 9). Psychiatric manifestations could be classified as affective disorder spectrum ( n = 11) and schizophreniform-illness ( n = 3). While the psychiatric symptoms improved in five patients with de-coppering therapy, seven patients needed symptomatic treatment as well. Three of the four patients who responded to de-coppering therapy were sensitive to neuroleptics. Long-term follow up of 10 patients revealed variable recovery. Conclusions Young patient with psychiatric manifestations with clues like history of jaundice, family history of neuropsychiatric manifestations and sensitivity to neuroleptics should be evaluated for WD to avoid delay in diagnosis and associated morbidity. Significant outcomes The study reemphasizes the importance of behavioral manifestations in Wilson disease in terms of diagnosis and management difficulties. Limitations Retrospective nature of the study.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Behavioral changes</subject><subject>Biological and medical sciences</subject><subject>Chelating Agents - therapeutic use</subject><subject>Cohort Studies</subject><subject>Copper - antagonists & inhibitors</subject><subject>Copper - blood</subject><subject>Copper - urine</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Depressive Disorder - etiology</subject><subject>Depressive Disorder - psychology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Hepatolenticular Degeneration - diagnosis</subject><subject>Hepatolenticular Degeneration - psychology</subject><subject>Hepatolenticular Degeneration - therapy</subject><subject>Humans</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mental Disorders - etiology</subject><subject>Mental Disorders - psychology</subject><subject>Mood Disorders - etiology</subject><subject>Mood Disorders - psychology</subject><subject>Neurology</subject><subject>Penicillamine - therapeutic use</subject><subject>Psychiatric symptoms</subject><subject>Psychosis</subject><subject>Psychotic Disorders - etiology</subject><subject>Psychotic Disorders - psychology</subject><subject>Schizophrenia - etiology</subject><subject>Wilson's disease</subject><subject>Zinc Sulfate - therapeutic use</subject><issn>0022-510X</issn><issn>1878-5883</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU2L1TAUhoMozp3RH-BGulFXrSftNB8KwjDjFwy4UNFdSJPTuam96TWnFe6_N-VeFFy4SgLPe_LyHMaecKg4cPFyqIZIVQ0gK9AVgL7HNlxJVbZKNffZBqCuy5bD9zN2TjQAgFBKP2RnXGq45AI2zNxMuxBtnIs9Hdw22DkFV-xsDD3SbOcwRSpCLL6Fkab4ggofCC3hq-IqX-1dnGjOARt9MW8x2T0u69tt7ThivMNH7EFvR8LHp_OCfX339sv1h_L20_uP11e3pWuhnsvLjkOrAdvctuMShWt8L7T1XnQC0bbCe4mytqKXGqVthATttELsOXLbNRfs-XHuPk0_l1zd7AI5HEcbcVrISKilEqrOID-CLk1ECXuzT2Fn08FwMKtVM5hs1axWDWiTrebM09Pwpduh_5s4aczAsxNgydmxTza6QH-4PEtxyUXmXh85zCp-BUyGXMDo0IeEbjZ-Cv-t8eaftBtDDPnDH3hAGqYlxezYcEO1AfN5Xf-6fZB58Y1omt81RKuR</recordid><startdate>20080315</startdate><enddate>20080315</enddate><creator>Srinivas, K</creator><creator>Sinha, S</creator><creator>Taly, A.B</creator><creator>Prashanth, L.K</creator><creator>Arunodaya, G.R</creator><creator>Janardhana Reddy, Y.C</creator><creator>Khanna, S</creator><general>Elsevier B.V</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080315</creationdate><title>Dominant psychiatric manifestations in Wilson's disease: A diagnostic and therapeutic challenge</title><author>Srinivas, K ; Sinha, S ; Taly, A.B ; Prashanth, L.K ; Arunodaya, G.R ; Janardhana Reddy, Y.C ; Khanna, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c502t-4b10590e5510b17e6c3df69add6b6eea56dd7e72a6f79e7a36709c98eef1e1ab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Behavioral changes</topic><topic>Biological and medical sciences</topic><topic>Chelating Agents - therapeutic use</topic><topic>Cohort Studies</topic><topic>Copper - antagonists & inhibitors</topic><topic>Copper - blood</topic><topic>Copper - urine</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Depressive Disorder - etiology</topic><topic>Depressive Disorder - psychology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Hepatolenticular Degeneration - diagnosis</topic><topic>Hepatolenticular Degeneration - psychology</topic><topic>Hepatolenticular Degeneration - therapy</topic><topic>Humans</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mental Disorders - etiology</topic><topic>Mental Disorders - psychology</topic><topic>Mood Disorders - etiology</topic><topic>Mood Disorders - psychology</topic><topic>Neurology</topic><topic>Penicillamine - therapeutic use</topic><topic>Psychiatric symptoms</topic><topic>Psychosis</topic><topic>Psychotic Disorders - etiology</topic><topic>Psychotic Disorders - psychology</topic><topic>Schizophrenia - etiology</topic><topic>Wilson's disease</topic><topic>Zinc Sulfate - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Srinivas, K</creatorcontrib><creatorcontrib>Sinha, S</creatorcontrib><creatorcontrib>Taly, A.B</creatorcontrib><creatorcontrib>Prashanth, L.K</creatorcontrib><creatorcontrib>Arunodaya, G.R</creatorcontrib><creatorcontrib>Janardhana Reddy, Y.C</creatorcontrib><creatorcontrib>Khanna, S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the neurological sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Srinivas, K</au><au>Sinha, S</au><au>Taly, A.B</au><au>Prashanth, L.K</au><au>Arunodaya, G.R</au><au>Janardhana Reddy, Y.C</au><au>Khanna, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dominant psychiatric manifestations in Wilson's disease: A diagnostic and therapeutic challenge</atitle><jtitle>Journal of the neurological sciences</jtitle><addtitle>J Neurol Sci</addtitle><date>2008-03-15</date><risdate>2008</risdate><volume>266</volume><issue>1</issue><spage>104</spage><epage>108</epage><pages>104-108</pages><issn>0022-510X</issn><eissn>1878-5883</eissn><coden>JNSCAG</coden><abstract>Abstract Introduction Recognition of psychiatric manifestations of Wilson's disease (WD) has diagnostic and therapeutic implications. Objective To describe the clinical features and psychopathology of patients with WD who had initial or predominant psychiatric manifestations. Patient and methods Records of 15 patients with WD (M:F: 11:4), from a large cohort of 350 patients, with predominant psychiatric manifestations at onset were reviewed. Their initial diagnosis, demographic profile, family history, pre-morbid personality, clinical manifestations, treatment and outcome were recorded. Results Their mean age at diagnosis was 19.8 ± 5.8 years. Six patients were born to consanguineous parentage and two patients each had family history of WD and past history of psychiatric illness. Diagnosis of WD was suspected by detection of KF rings (all), observing sensitivity to neuroleptics ( n = 2), history of jaundice ( n = 2) and family history suggestive of WD ( n = 9). Psychiatric manifestations could be classified as affective disorder spectrum ( n = 11) and schizophreniform-illness ( n = 3). While the psychiatric symptoms improved in five patients with de-coppering therapy, seven patients needed symptomatic treatment as well. Three of the four patients who responded to de-coppering therapy were sensitive to neuroleptics. Long-term follow up of 10 patients revealed variable recovery. Conclusions Young patient with psychiatric manifestations with clues like history of jaundice, family history of neuropsychiatric manifestations and sensitivity to neuroleptics should be evaluated for WD to avoid delay in diagnosis and associated morbidity. Significant outcomes The study reemphasizes the importance of behavioral manifestations in Wilson disease in terms of diagnosis and management difficulties. Limitations Retrospective nature of the study.</abstract><cop>Shannon</cop><pub>Elsevier B.V</pub><pmid>17904160</pmid><doi>10.1016/j.jns.2007.09.009</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-510X |
ispartof | Journal of the neurological sciences, 2008-03, Vol.266 (1), p.104-108 |
issn | 0022-510X 1878-5883 |
language | eng |
recordid | cdi_proquest_miscellaneous_70278682 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Adolescent Adult Behavioral changes Biological and medical sciences Chelating Agents - therapeutic use Cohort Studies Copper - antagonists & inhibitors Copper - blood Copper - urine Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Depressive Disorder - etiology Depressive Disorder - psychology Female Follow-Up Studies Hepatolenticular Degeneration - diagnosis Hepatolenticular Degeneration - psychology Hepatolenticular Degeneration - therapy Humans Longitudinal Studies Male Medical sciences Mental Disorders - etiology Mental Disorders - psychology Mood Disorders - etiology Mood Disorders - psychology Neurology Penicillamine - therapeutic use Psychiatric symptoms Psychosis Psychotic Disorders - etiology Psychotic Disorders - psychology Schizophrenia - etiology Wilson's disease Zinc Sulfate - therapeutic use |
title | Dominant psychiatric manifestations in Wilson's disease: A diagnostic and therapeutic challenge |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T18%3A50%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dominant%20psychiatric%20manifestations%20in%20Wilson's%20disease:%20A%20diagnostic%20and%20therapeutic%20challenge&rft.jtitle=Journal%20of%20the%20neurological%20sciences&rft.au=Srinivas,%20K&rft.date=2008-03-15&rft.volume=266&rft.issue=1&rft.spage=104&rft.epage=108&rft.pages=104-108&rft.issn=0022-510X&rft.eissn=1878-5883&rft.coden=JNSCAG&rft_id=info:doi/10.1016/j.jns.2007.09.009&rft_dat=%3Cproquest_cross%3E70278682%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70278682&rft_id=info:pmid/17904160&rft_els_id=S0022510X07006363&rfr_iscdi=true |